Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Dowell

Showing results (41-50 of 114) with videos related to

Pageof 12
Sort By:
Journal of Clinical Pharmacology|March 26, 2009
Pharmacokinetics of dalbavancin in patients with renal or hepatic impairmentThomas Marbury, James A Dowell, Elyse Seltzer, et al.
Journal of Clinical Pharmacology|May 21, 2008
Population pharmacokinetic modeling of epoetin delta in pediatric patients with chronic kidney diseaseWilliam Knebel, Mary Palmen, James A Dowell, et al.
Healthcare Financial Management : Journal of the Healthcare Financial Management Association|August 14, 2001
Developing mechanisms for reporting compliance violationsM A Dowell, A G Russell, J H Gordon
Journal of Clinical Pharmacology|March 29, 2007
Anidulafungin does not require dosage adjustment in subjects with varying degrees of hepatic or renal impairmentJames A Dowell, Martin Stogniew, David Krause, et al.
Journal of Clinical Pharmacology|November 18, 2005
Safety and pharmacokinetics of coadministered voriconazole and anidulafunginJames A Dowell, Jennifer Schranz, Alice Baruch, et al.
Clinical Therapeutics|September 11, 2007
Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney diseaseWilliam B Smith, James A Dowell, Raymond D Pratt
Journal of Pharmaceutical Sciences|January 6, 1999
Artificial neural networks applied to the in vitro-in vivo correlation of an extended-release formulation: initial trials and experienceJ A Dowell, A Hussain, J Devane, et al.
Quintessence International (Berlin, Germany : 1985)|November 1, 1990
Relationship among visible light source, composite resin polymerization shrinkage, and hygroscopic expansionK J Donly, A Dowell, C Anixiadas, et al.
Advanced Drug Delivery Reviews|March 4, 2000
Noninvasive measurements for studying the tumoral pharmacokinetics of platinum anticancer drugs in solid tumorsJ A Dowell, A R Sancho, D Anand, et al.
Psychological Reports|August 1, 1991
When are AIDS patients to blame for their disease? Effects of patients' sexual orientation and mode of transmissionK A Dowell, C T Lo Presto, M F Sherman
Pageof 12

Showing results (41-50 of 114) with videos related to

Sort By:
Pageof 12
Journal of Clinical Pharmacology|March 26, 2009
Pharmacokinetics of dalbavancin in patients with renal or hepatic impairmentThomas Marbury, James A Dowell, Elyse Seltzer, et al.
Journal of Clinical Pharmacology|May 21, 2008
Population pharmacokinetic modeling of epoetin delta in pediatric patients with chronic kidney diseaseWilliam Knebel, Mary Palmen, James A Dowell, et al.
Healthcare Financial Management : Journal of the Healthcare Financial Management Association|August 14, 2001
Developing mechanisms for reporting compliance violationsM A Dowell, A G Russell, J H Gordon
Journal of Clinical Pharmacology|March 29, 2007
Anidulafungin does not require dosage adjustment in subjects with varying degrees of hepatic or renal impairmentJames A Dowell, Martin Stogniew, David Krause, et al.
Journal of Clinical Pharmacology|November 18, 2005
Safety and pharmacokinetics of coadministered voriconazole and anidulafunginJames A Dowell, Jennifer Schranz, Alice Baruch, et al.
Clinical Therapeutics|September 11, 2007
Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney diseaseWilliam B Smith, James A Dowell, Raymond D Pratt
Journal of Pharmaceutical Sciences|January 6, 1999
Artificial neural networks applied to the in vitro-in vivo correlation of an extended-release formulation: initial trials and experienceJ A Dowell, A Hussain, J Devane, et al.
Quintessence International (Berlin, Germany : 1985)|November 1, 1990
Relationship among visible light source, composite resin polymerization shrinkage, and hygroscopic expansionK J Donly, A Dowell, C Anixiadas, et al.
Advanced Drug Delivery Reviews|March 4, 2000
Noninvasive measurements for studying the tumoral pharmacokinetics of platinum anticancer drugs in solid tumorsJ A Dowell, A R Sancho, D Anand, et al.
Psychological Reports|August 1, 1991
When are AIDS patients to blame for their disease? Effects of patients' sexual orientation and mode of transmissionK A Dowell, C T Lo Presto, M F Sherman
Pageof 12